Lonza's stem cell production insight a boon to innovation and business
Investments in manufacturing and science have left Lonza well placed to cope with skyrocketing demand for stem cell manufacturing, the CMO says.
Archives for September 27, 2015
US FDA withdraws approval for Sun migraine drug over concerns about Halol plant
The US FDA has revoked approval for Sun Pharmaceutical Industries’ extended-release epilepsy drug Elepsia XR over concerns the firm's manufacturing plant in Halol, India does not meet quality standards.
Drug delivery tech contractor 3M teams with MedImmune on cancer drug development
Contractor 3M Drug delivery has licensed a molecule with potential as a cancer treatment to MedImmune.
Evonik hikes up pharma excipient prices
Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.
GSK will create 300 new production jobs in France despite R&D pull out
GSK in France: 'Oui' to manufacturing, 'non' to R&D
GSK is selling a French R&D site as part of a global restructuring move but says it will continue growing its manufacturing presence in the country.